UTILIZATION OF TRANSGENIC MICE IN THE STUDY OF MATRIX-DEGRADING PROTEINASES AND THEIR INHIBITORS

被引:18
作者
KHOKHA, R [1 ]
MARTIN, DC [1 ]
FATA, JE [1 ]
机构
[1] UNIV WESTERN ONTARIO,LONDON REG CANC CTR,DEPT BIOCHEM,LONDON,ON N6A 4L6,CANADA
关键词
METALLOPROTEINASES; SERINE PROTEINASES; PROTEINASE INHIBITORS; EXTRACELLULAR MATRIX; TRANSGENIC MICE;
D O I
10.1007/BF00665794
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The extracellular matrix (ECM) acts as both a structural scaffold and an informational medium. Its dynamic status is determined by cells that secrete its constituent molecules and, in most cases, also secrete enzymes that catalyze degradation of these molecules. A stasis between ECM degrading enzymes and their inhibitors maintains the integrity of the matrix. While controlled ECM remodelling is fundamental to several normal processes, uncontrolled disruption underlies diverse pathological conditions. Transgenic mice with specific modulations or a total lack of expression of certain metalloproteinases, serine proteinases or their inhibitors have been generated to elucidate endogenous expression patterns, identify regulatory elements of these genes, and study the physiological consequences of their deregulated expression. With these models we enhance our understanding of the role of proteinases and their inhibitors in diverse normal processes and pathologies including mammary gland development, hemostasis, emphysema and cancer.
引用
收藏
页码:97 / 111
页数:15
相关论文
共 111 条
[61]   CANCER METASTASIS AND ANGIOGENESIS - AN IMBALANCE OF POSITIVE AND NEGATIVE REGULATION [J].
LIOTTA, LA ;
STEEG, PS ;
STETLERSTEVENSON, WG .
CELL, 1991, 64 (02) :327-336
[62]  
MACEONALD RJ, 1987, HEPATOLOGY, V7, pS42
[63]  
Martin D. C., 1994, Clinical and Experimental Metastasis, V12, P12
[64]  
Matrisian L.M., 1990, Current Topics in Developmental Biology, V24, P219, DOI 10.1016/S0070-2153(08)60089-7
[65]   THE MATRIX-DEGRADING METALLOPROTEINASES [J].
MATRISIAN, LM .
BIOESSAYS, 1992, 14 (07) :455-463
[66]   THE MESSENGER-RNA CODING FOR THE SECRETED PROTEASE TRANSIN IS EXPRESSED MORE ABUNDANTLY IN MALIGNANT THAN IN BENIGN-TUMORS [J].
MATRISIAN, LM ;
BOWDEN, GT ;
KRIEG, P ;
FURSTENBERGER, G ;
BRIAND, JP ;
LEROY, P ;
BREATHNACH, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (24) :9413-9417
[67]   OVEREXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN TRANSGENIC MICE IS CORRELATED WITH IMPAIRED LEARNING [J].
MEIRI, N ;
MASOS, T ;
ROSENBLUM, K ;
MISKIN, R ;
DUDAI, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :3196-3200
[68]   BIOLOGY AND BIOCHEMISTRY OF PROTEINASES IN TUMOR INVASION [J].
MIGNATTI, P ;
RIFKIN, DB .
PHYSIOLOGICAL REVIEWS, 1993, 73 (01) :161-195
[69]  
MIGNATTI P, 1988, MOL CELLULAR BIOL WO, P497
[70]   HUMAN AND MURINE UROKINASE CDNAS LINKED TO THE MURINE ALPHA-A-CRYSTALLIN PROMOTER EXHIBIT LENS AND NONLENS EXPRESSION IN TRANSGENIC MICE [J].
MISKIN, R ;
AXELROD, JH ;
GRIEP, AE ;
LEE, E ;
BELIN, D ;
VASSALLI, JD ;
WESTPHAL, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 190 (01) :31-38